Now showing 1 - 6 of 6
  • 2016Journal Article Research Paper
    [["dc.bibliographiccitation.firstpage","2710"],["dc.bibliographiccitation.issue","12"],["dc.bibliographiccitation.journal","Biophysical Journal"],["dc.bibliographiccitation.lastpage","2719"],["dc.bibliographiccitation.volume","110"],["dc.contributor.author","Shabardina, Victoria"],["dc.contributor.author","Kramer, Corinna"],["dc.contributor.author","Gerdes, Benjamin"],["dc.contributor.author","Braunger, Julia A."],["dc.contributor.author","Cordes, Andrea"],["dc.contributor.author","Schäfer, Jonas"],["dc.contributor.author","Mey, Ingo"],["dc.contributor.author","Grill, David"],["dc.contributor.author","Gerke, Volker"],["dc.contributor.author","Steinem, Claudia"],["dc.date.accessioned","2017-09-07T11:44:51Z"],["dc.date.available","2017-09-07T11:44:51Z"],["dc.date.issued","2016"],["dc.description.abstract","Ezrin, a protein of the ezrin, radixin, moesin (ERM) family, provides a regulated linkage between the plasma membrane and the cytoskeleton. The hallmark of this linkage is the activation of ezrin by phosphatidylinositol-4,5-bisphosphate (PIP2) binding and a threonine phosphorylation at position 567. To analyze the influence of these activating factors on the organization of ezrin on lipid membranes and the proposed concomitant oligomer-monomer transition, we made use of supported lipid bilayers in conjunction with atomic force microscopy and fluorescence microscopy. Bilayers doped with either PIP2 as the natural receptor lipid of ezrin or a Ni-nitrilotriacetic acid-equipped lipid to bind the proteins via their His6-tags to the lipid membrane were used to bind two different ezrin variants: ezrin wild-type and ezrin T567D mimicking the phosphorylated state. Using a combination of reflectometric interference spectroscopy, atomic force microscopy, and Forster resonance energy transfer experiments, we show that only the ezrin T567D mutant, upon binding to PIP2-containing bilayers, undergoes a remarkable conformational change, which we attribute to an opening of the conformation resulting in monomeric protein on the lipid bilayer."],["dc.identifier.doi","10.1016/j.bpj.2016.05.009"],["dc.identifier.gro","3141663"],["dc.identifier.isi","000378383300018"],["dc.identifier.pmid","27332129"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/6786"],["dc.language.iso","en"],["dc.notes.intern","WoS Import 2017-03-10"],["dc.notes.status","final"],["dc.notes.submitter","PUB_WoS_Import"],["dc.relation.eissn","1542-0086"],["dc.relation.issn","0006-3495"],["dc.title","Mode of Ezrin-Membrane Interaction as a Function of PIP2 Binding and Pseudophosphorylation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS
  • 2018Journal Article
    [["dc.bibliographiccitation.firstpage","740"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","British Journal of Dermatology"],["dc.bibliographiccitation.lastpage","748"],["dc.bibliographiccitation.volume","178"],["dc.contributor.author","Mössner, R."],["dc.contributor.author","Wilsmann-Theis, D."],["dc.contributor.author","Oji, V."],["dc.contributor.author","Gkogkolou, P."],["dc.contributor.author","Löhr, S."],["dc.contributor.author","Schulz, P."],["dc.contributor.author","Körber, A."],["dc.contributor.author","Prinz, J.C."],["dc.contributor.author","Renner, R."],["dc.contributor.author","Schäkel, K."],["dc.contributor.author","Vogelsang, L."],["dc.contributor.author","Peters, K.-P."],["dc.contributor.author","Philipp, S."],["dc.contributor.author","Reich, K."],["dc.contributor.author","Ständer, H."],["dc.contributor.author","Jacobi, A."],["dc.contributor.author","Weyergraf, A."],["dc.contributor.author","Kingo, K."],["dc.contributor.author","Kõks, S."],["dc.contributor.author","Gerdes, S."],["dc.contributor.author","Steinz, K."],["dc.contributor.author","Schill, T."],["dc.contributor.author","Griewank, K. G."],["dc.contributor.author","Müller, M."],["dc.contributor.author","Frey, S."],["dc.contributor.author","Ebertsch, L."],["dc.contributor.author","Uebe, S."],["dc.contributor.author","Sticherling, M."],["dc.contributor.author","Sticht, H."],["dc.contributor.author","Hüffmeier, U."],["dc.date.accessioned","2020-12-10T18:26:58Z"],["dc.date.available","2020-12-10T18:26:58Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1111/bjd.15867"],["dc.identifier.issn","0007-0963"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/76214"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","The genetic basis for most patients with pustular skin disease remains elusive"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]
    Details DOI
  • 2018Journal Article
    [["dc.bibliographiccitation.firstpage","6497"],["dc.bibliographiccitation.issue","25"],["dc.bibliographiccitation.journal","Analytical and Bioanalytical Chemistry"],["dc.bibliographiccitation.lastpage","6505"],["dc.bibliographiccitation.volume","410"],["dc.contributor.author","Gerdes, Benjamin"],["dc.contributor.author","Rixen, Rebecca M."],["dc.contributor.author","Kramer, Kristina"],["dc.contributor.author","Forbrig, Enrico"],["dc.contributor.author","Hildebrandt, Peter"],["dc.contributor.author","Steinem, Claudia"],["dc.date.accessioned","2020-12-10T14:09:55Z"],["dc.date.available","2020-12-10T14:09:55Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1007/s00216-018-1248-7"],["dc.identifier.eissn","1618-2650"],["dc.identifier.issn","1618-2642"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70600"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Quantification of Hv1-induced proton translocation by a lipid-coupled Oregon Green 488-based assay"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]
    Details DOI
  • 2015Conference Abstract
    [["dc.bibliographiccitation.journal","European Biophysics Journal"],["dc.bibliographiccitation.volume","44"],["dc.contributor.author","Gerdes, B."],["dc.contributor.author","Friedrich, Thomas"],["dc.contributor.author","Steinem, Claudia"],["dc.date.accessioned","2018-11-07T09:55:31Z"],["dc.date.available","2018-11-07T09:55:31Z"],["dc.date.issued","2015"],["dc.format.extent","S215"],["dc.identifier.isi","000380001400660"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/36764"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","New york"],["dc.relation.eventlocation","Dresden"],["dc.relation.issn","1432-1017"],["dc.relation.issn","0175-7571"],["dc.title","Reconstitution and characterization of a recombinant voltage-gated proton channel Hv1"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details WOS
  • 2020Journal Article
    [["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.journal","The Journal of Dermatological Treatment"],["dc.bibliographiccitation.lastpage","5"],["dc.contributor.author","Kromer, C."],["dc.contributor.author","Wilsmann-Theis, D."],["dc.contributor.author","Gerdes, S."],["dc.contributor.author","Krebs, S."],["dc.contributor.author","Pinter, A."],["dc.contributor.author","Philipp, S."],["dc.contributor.author","Mössner, R."],["dc.date.accessioned","2020-12-10T18:14:55Z"],["dc.date.available","2020-12-10T18:14:55Z"],["dc.date.issued","2020"],["dc.identifier.doi","10.1080/09546634.2020.1716932"],["dc.identifier.eissn","1471-1753"],["dc.identifier.issn","0954-6634"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/74664"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker – a retrospective multicenter study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]
    Details DOI
  • 2004Journal Article
    [["dc.bibliographiccitation.firstpage","902"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","International Journal of Cancer"],["dc.bibliographiccitation.lastpage","906"],["dc.bibliographiccitation.volume","110"],["dc.contributor.author","Bartsch, D. K."],["dc.contributor.author","Kress, Rainer"],["dc.contributor.author","Sina-Frey, M."],["dc.contributor.author","Grutzmann, R."],["dc.contributor.author","Gerdes, B."],["dc.contributor.author","Pilarsky, C."],["dc.contributor.author","Heise, J. W."],["dc.contributor.author","Schulte, K. M."],["dc.contributor.author","Colombo-Benkmann, M."],["dc.contributor.author","Schleicher, C."],["dc.contributor.author","Witzigmann, Helmut"],["dc.contributor.author","Pridohl, O."],["dc.contributor.author","Ghadimi, Michael B."],["dc.contributor.author","Horstmann, Olaf"],["dc.contributor.author","von Bernstorff, W."],["dc.contributor.author","Jochimsen, L."],["dc.contributor.author","Schmidt, J."],["dc.contributor.author","Eisold, S."],["dc.contributor.author","Estevez-Schwarz, L."],["dc.contributor.author","Hahn, S. A."],["dc.contributor.author","Schulmann, K."],["dc.contributor.author","Bock, W."],["dc.contributor.author","Gress, Thomas M."],["dc.contributor.author","Zugel, N."],["dc.contributor.author","Breitschaft, K."],["dc.contributor.author","Prenzel, K."],["dc.contributor.author","Messmann, H."],["dc.contributor.author","Endlicher, E."],["dc.contributor.author","Schneider, M."],["dc.contributor.author","Ziegler, Andreas"],["dc.contributor.author","Schmiegel, W."],["dc.contributor.author","Schafer, H."],["dc.contributor.author","Rothmund, M."],["dc.contributor.author","Rieder, H."],["dc.date.accessioned","2018-11-07T10:47:12Z"],["dc.date.available","2018-11-07T10:47:12Z"],["dc.date.issued","2004"],["dc.description.abstract","Based on several case-control studies, it has been estimated that familial aggregation and genetic susceptibility play a role in up to 10% of patients with pancreatic cancer, although conclusive epidemiologic data are still lacking. Therefore, we evaluated the prevalence of familial pancreatic cancer and differences to its sporadic form in a. prospective multicenter trial. A total of 479 consecutive patients with newly diagnosed, histologically confirmed adenocarcinoma of the pancreas were prospectively evaluated regarding medical and family history, treatment and pathology of the tumour. A family history for pancreatic cancer was confirmed whenever possible by reviewing the tumour specimens and medical reports. Statistical analysis was performed by calculating odds ratios, regression analysis with a logit-model and the Kaplan-Meier method. Twenty-three of 479 (prevalence 4.8%, 95% CI 3.1-7.1) patients reported at least 1 first-degree relative with pancreatic cancer. The familial aggregation could be confirmed by histology in 5 of 23 patients (1.1%, 95% CI 0.3-2.4), by medical records in 9 of 23 patients (1.9%, 95% CI 0.9-33) and by standardized interviews of first-degree relatives in 17 of 23 patients (33%, 95% CI 2.1-5.6), respectively. There were no statistical significant differences between familial and sporadic pancreatic cancer cases regarding sex ratio, age of onset, presence of diabetes mellitus and pancreatitis, tumour histology and stage, prognosis after palliative or curative treatment as well as associated tumours in index patients and families, respectively. The prevalence of familial pancreatic cancer in Germany is at most 3.5% (range 1.1-3.5%) depending on the mode of confirmation of the pancreatic carcinoma in relatives. This prevalence is lower than so far postulated in the literature. There were no significant clinical differences between the familial and sporadic form of pancreatic cancer. (C) 2004 Wiley-Liss, Inc."],["dc.identifier.doi","10.1002/ijc.20210"],["dc.identifier.isi","000222048600017"],["dc.identifier.pmid","15170674"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/47917"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-liss"],["dc.relation.issn","0020-7136"],["dc.title","Prevalence of familial pancreatic cancer in Germany"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]
    Details DOI PMID PMC WOS